Mintz Advises on ArriVent BioPharma's Upsized IPO on the Nasdaq Global Market

Retrieved on: 2024-02-01 19:24:26

Tags for this article:

Initial public offering

Corporate finance

Public offering

Underwriting

Stock market

ArriVent Biopharma Inc.

Click the tags to see associated articles and topics

Mintz Advises on ArriVent BioPharma's Upsized IPO on the Nasdaq Global Market. View article details on hiswai:

Summary

The article describes ArriVent Biopharma Inc.'s successful IPO in the biopharma sector, issuing shares on the NASDAQ with Mintz law firm advising, involving key corporate finance concepts like underwriting and the stock market.

Article found on: www.mintz.com

View Original Article